Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for early frailty and muscle weakness in older adults
ISRCTN29932357Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Fragility and Sarcopenia comparing Metformin with Placebo (2 arms). Primary endpoint: 4-m walk speed at 4 months. Started Apr 2021; status: completed.
02
Drugs
metformin
03
Conditions
FragilitySarcopenia
Beyond the preview
Go deeper on ISRCTN29932357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29932357.